Getinge said Tuesday it will phase out its surgical perfusion business and reallocate resources to higher-growth areas such as extracorporeal membrane oxygenation (ECMO) and transplant care. CEO ...
Getinge today announced the launch of the Vasoview Hemopro 3 Endoscopic Vessel Harvesting (EVH) System, including the Hemopro 3 Harvesting Tool and dedicated Hemopro 3 Power Supply. Designed for ...
Getinge (OM:GETI B) plans significant board changes at its 2026 AGM. Shareholders are set to vote on the election of Camilla Sylvest to the board. New employee representatives are also expected to ...
Narrow-moat Getinge GETI B reported third-quarter earnings above our expectations. We are increasing our fair value estimate to SEK 247 from SEK 221, as Getinge is executing a turnaround in its acute ...
STOCKHOLM (Reuters) - Sweden's Getinge (GETIb.ST) said on Thursday it had agreed to sell its troubled surgical mesh business that saw the medical equipment maker swing to a loss in the third quarter ...
Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S. (Reuters) ...
GÖTEBORG, Sweden, July 24, 2020 /PRNewswire/ -- Today Getinge announces its intention to become a COâ‚‚neutral company by 2025. The target will be reached by a stepwise approach in several areas and ...
GOTHENBURG, Sweden, Sept. 30, 2020 /PRNewswire/ -- Born 12 weeks too early with a 50/50 chance at survival, Sabina Checketts has grown up to become a neonatal doctor herself, using new therapies and ...
Getinge announced today that a court delivered a verdict in favor of Johnson & Johnson’s Abiomed in a patent spat with its Maquet subsidiary.
Getinge, a Swedish public limited company, announced on September 11, 2024 that it completed acquisition of Paragonix Technologies, Inc., a U.S. company specializing in organ transport products and ...
Price hikes and cost saving measures aid Getinge's earnings growth Absorbs chunk of near-term tariff costs before pricing measures fully bite US probe into medtech imports doesn't affect Getinge, CEO ...
Getinge has completed an Initial Launch of the Vasoview Hemopro 3 EVH System and has received valuable, positive customer feedback. Getinge has continuously refined EVH technology with a focus on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results